scispace - formally typeset
S

Sreeram V Ramagopalan

Researcher at Bristol-Myers Squibb

Publications -  54
Citations -  594

Sreeram V Ramagopalan is an academic researcher from Bristol-Myers Squibb. The author has contributed to research in topics: Apixaban & Population. The author has an hindex of 9, co-authored 54 publications receiving 382 citations. Previous affiliations of Sreeram V Ramagopalan include Wellcome Trust Centre for Human Genetics & University Hospital of Basel.

Papers
More filters
Journal ArticleDOI

A comparative study of CSF neurofilament light and heavy chain protein in MS.

TL;DR: NfL proved to be a stable protein, an important prerequisite for a reliable biomarker, and the NF-light® ELISA performed better in discriminating patients from controls, compared with the ECL-NfHSMI35 immunoassay, which confirmed and expanded the role of neurofilaments as quantitative markers of neurodegeneration.
Journal ArticleDOI

Prodromal symptoms of multiple sclerosis in primary care

TL;DR: Early diagnosis and treatment initiation significantly influence long‐term disability outcome in multiple sclerosis and this work aimed at identifying prodromal symptoms of MS in primary care settings.
Journal ArticleDOI

Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants.

TL;DR: The fundamentals of propensity score matching and inverse probability of treatment weighting are described, differences between them are appraised and applied examples are presented to elevate understanding of these methods within the atrial fibrillation field.
Journal ArticleDOI

Real-world data and the patient perspective: the PROmise of social media?

TL;DR: In most healthcare systems, patient-reported outcomes are not regularly collected or recorded as part of routine clinical care, despite evidence that doing so can have tangible clinical benefit as discussed by the authors, and therefore, research is beginning to turn to social media as a novel means to capture the patient voice.
Journal ArticleDOI

COPD exacerbations by disease severity in England.

TL;DR: Patients in the most severe category (GOLD D) experienced nearly three times the number of exacerbations and COPD-related hospitalizations as those in the least severe category(GOLD A), in addition to increased general practitioner visits.